Skip to content
Likelier
Cancer · reviewed 2026-04-11

What are the odds of dying from liver cancer?

Evidence quality 4.75/5

Eight-dimension review score against the quality rubric . Each dimension scored 1–5.

D1 Source grounding
5/5
D2 Source authority
5/5
D3 Arithmetic
4/5
D4 Uncertainty
4/5
D5 Scope
5/5
D6 Prose
5/5
D7 Perception honesty
5/5
D8 Caveat completeness
5/5
Average 4.75/5
Direct evidence

Lifetime probability · lifetime, global adult

1 in 59

1.7% lifetime chance

Most people underestimate this.

range 1 in 143 to 1 in 33

lifetime, global adult each band = 10× rarer → zoomed to your factors See full scale →
certain 1 in 1K 1 in 1M 1 in 1B
1 in 1.7 1 in 588

● your factors — click this risk ▾ to reveal

≈ As likely as

A single pale oblong shape with an uneven boundary on a muted sand background, flat vector illustration.

Perceived

Liver cancer is one of the cancer sites where the public’s mental model is least calibrated. Most adults in wealthy countries file it as a rare, alcoholic’s disease — vaguely "one of the bad ones" but not a top-of-mind killer the way lung or breast cancer is. The arithmetic disagrees. Liver cancer is the **third leading cause of cancer death worldwide**, behind only lung and colorectal, ahead of breast and stomach. It sits in the global top five by a wide margin precisely because the dominant driver — chronic hepatitis B — is endemic across East and Southeast Asia and much of Sub-Saharan Africa, regions where it quietly produces one of the world’s largest cancer mortality burdens. The typical US reader encounters it as a footnote; the typical Chinese or Vietnamese reader does not.

Rough estimate: 50% of US adults are very or somewhat worried about getting cancer (Gallup, all sites); liver cancer rarely registers as a named worry in high-income countries

Source: Gallup (2021) — Cancer, Heart Disease Worries Eclipse COVID-19

Actual

~758,000 liver cancer deaths per year globally (~7.8% of all cancer deaths, #3 cancer killer)

global, all ages, liver and intrahepatic bile duct cancer

Show derivation

Uses the GLOBOCAN 2022 estimate of 758,725 liver cancer deaths per year globally (866,136 new cases), making liver cancer the third leading cause of cancer death worldwide behind lung and colorectal. Across a global adult population of ~6.0 billion (age 18+), that is an annual per-adult rate of roughly 0.126 per 1,000. Naive 60-year compounding: 1 − (1 − 0.000126)^60 ≈ 0.0075. That is a floor, because liver cancer mortality is heavily concentrated in the 60-80 band and naive compounding treats risk as age-flat; age-weighting pulls the realistic global figure to roughly 0.015-0.020. The headline 0.017 (≈ 1 in 60) sits at that age-weighted mid-point. The regional spread around this global average is enormous — roughly tenfold between low-incidence Western countries (Northern America age-standardised mortality ~6.7 per 100,000) and high-incidence parts of East Asia (age-standardised mortality ~11-14 per 100,000) — and is driven almost entirely by the geographic distribution of chronic hepatitis B infection. The direct SEER US lifetime figure for developing liver-and-intrahepatic-bile-duct cancer is 1.1%, and US lifetime mortality is closer to 0.7% given a five-year survival of ~22%. Headline figure 0.017 (≈ 1 in 60) with an uncertainty band of 0.007-0.030 to span the US adult low end and the age-weighted global high end. Scope is global-adult-lifetime because liver cancer has the largest region-to-region spread of any Likelier cancer entry, and a US-only headline would badly understate it.

Caveats: Liver cancer is the Likelier entry with the largest region-to-region variance of…

Liver cancer is the Likelier entry with the largest region-to-region variance of any cancer on the site, and a single headline number does a worse job than usual of summarising a reader’s actual risk. The ~1 in 60 global lifetime figure is an average across a population where East Asia and Sub-Saharan Africa carry a disproportionately large share of the global burden and where North America and Western Europe sit at roughly a third of the global age-standardised rate. The single biggest determinant of individual risk is chronic hepatitis B or hepatitis C status, which is binary for any given person and moves the lifetime number by more than an order of magnitude. The US number is itself moving: ACS reports US liver cancer incidence has tripled over the past four decades, driven partly by the HCV-exposed 1945-1965 birth cohort and partly by the rising NAFLD/MASLD burden, and is expected to continue rising as the NAFLD cohort ages. On the other side, universal infant HBV vaccination — routine in most countries since the 1990s — has already begun to bend the incidence curve in post-vaccination birth cohorts in Taiwan, mainland China, and elsewhere. The global liver cancer picture over the next 30 years is an uneven mix of falling HBV-driven incidence in vaccinated Asian cohorts and rising NAFLD-driven incidence in metabolically-unwell Western cohorts. Finally, "liver cancer" here is dominated by hepatocellular carcinoma (HCC), which is ~80% of primary liver cancer globally; intrahepatic cholangiocarcinoma and other subtypes are lumped in with HCC in the SEER and GLOBOCAN headline figures but have different risk-factor profiles and prognoses.

Regional breakdown

The headline figure averages across very different populations. Here’s how the probability varies by geography or context:

Region / context Lifetime probability Notes
Global average 1 in 67 ~758K liver cancer deaths/yr across ~6B adults (GLOBOCAN 2022); age-weighted lifetime
East/Southeast Asia 1 in 25 Dominated by chronic hepatitis B; Eastern Asia alone accounts for roughly half of global liver cancer deaths, reflecting decades of endemic HBV transmission before the vaccination era
Sub-Saharan Africa 1 in 40 HBV plus dietary aflatoxin exposure; incidence is high but competing mortality and under-reporting make the absolute lifetime figure uncertain
US adult 1 in 143 SEER lifetime diagnosis ~1.1%, 5-year survival ~22%, implied lifetime mortality ~0.7-0.9%; rising over the past four decades
Western Europe 1 in 125 Lower than East Asia; burden increasingly driven by HCV legacy infection, alcohol, and NAFLD/MASLD rather than HBV

Risks at similar odds

Other risks with roughly the same likelihood — useful for calibration.

cancer

Lung cancer

What are the odds of dying from lung cancer?

cancer

Colorectal cancer

What are the odds of dying from colorectal cancer?

cancer

Pancreatic cancer

What are the odds of dying from pancreatic cancer?

cancer

Cancer (any)

What are the odds of dying from cancer?

cancer

Prostate cancer

What are the odds of dying from prostate cancer?

cancer

Breast cancer

What are the odds of dying from breast cancer?

cancer

Cervical cancer

What are the odds of developing cervical cancer?

cancer

Charred meat & cancer

How much does eating charred or well-done grilled meat actually raise your cancer risk?

Compare to:

Liver cancer is the third leading cause of cancer death worldwide, and almost nobody in a wealthy country knows it. The IARC’s GLOBOCAN 2022 release puts the annual toll at 758,725 deaths — 7.8% of all global cancer deaths, behind only lung (18.7%) and colorectal (9.3%), and ahead of breast and stomach. Spread across a global adult population of roughly six billion and age-weighted for a normal 60-year adult lifespan, that works out to a lifetime mortality figure of about 1 in 60 for a generic adult alive today. For a US adult the number is much smaller: SEER puts the US lifetime risk of being diagnosed with liver or intrahepatic bile duct cancer at 1.1%, which combined with a 22% five-year survival gives a lifetime mortality closer to 0.7-0.9% — roughly one-fifth the age-standardised mortality rate of parts of Eastern Asia. The region-to- region spread is the largest of any cancer on this site.

What makes liver cancer an outlier in the Likelier catalogue is how tightly the global burden maps onto a single infectious agent. Chronic hepatitis B, rather than smoking or alcohol or diet, is by some distance the largest upstream driver. The WHO estimates 254 million people are living with chronic HBV worldwide and that hepatitis B caused about 1.1 million deaths in 2022, “mostly from cirrhosis and hepatocellular carcinoma.” Because HBV transmitted in infancy becomes chronic in roughly 95% of cases versus under 5% when acquired in adulthood, the geography of global HCC is effectively the geography of historical perinatal HBV transmission — which is why Eastern Asia alone accounts for roughly half of global liver cancer cases from about 30% of the world population. Taiwan’s 1984 universal infant HBV vaccination programme produced a ~70% reduction in childhood HCC within two decades, one of the cleanest cancer-prevention outcomes in the epidemiological literature. The hepatitis B vaccine is, in effect, a cancer vaccine. The perceived/actual gap here is wide enough that Likelier tags the entry underrated.

Where the number doesn’t apply: almost every specific reader. A vaccinated never-drinker with no chronic viral hepatitis runs a liver cancer mortality risk an order of magnitude below the US headline; a lifelong chronic HBV carrier with heavy alcohol use runs a risk an order of magnitude above it. The US number is also moving — ACS reports US liver cancer incidence has tripled over the past four decades, driven by the HCV-exposed 1945-1965 birth cohort and by the rising burden of non-alcoholic fatty liver disease (NAFLD, now often called MASLD). NAFLD is the emerging liver cancer driver in wealthy countries, tied to obesity, type 2 diabetes, and metabolic syndrome; the relative risk per person is much smaller than chronic HBV, but the exposed population is vastly larger, so the population-attributable fraction is rising. Direct-acting antivirals for HCV, introduced after 2013, have begun to reverse one of those pressures; the NAFLD pressure is still building. The next 30 years of the global liver cancer curve will be an uneven mix of vaccinated Asian cohorts aging out of the HBV era and metabolically-unwell Western cohorts aging into the NAFLD one.

Claim ledger

Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.

  1. [1] International Agency for Research on Cancer (IARC) / World Health Organization — New report on global cancer burden in 2022 by world region and human development level
    New report on global cancer burden in 2022 by world region and human development level

    See all 3 Likelier entries citing this source →

    Statistic
    In 2022 liver cancer was the third leading cause of cancer death globally (7.8% of all cancer deaths), behind lung (18.7%) and colorectal (9.3%)
    Excerpt
    “"the next most common causes were colorectal (9.3%) and liver cancer (7.8%)." ”
    Source data from
    2024-04-04
    Accessed
    2026-04-11 · archived copy
    Calculation
    IARC’s 7.8% of cancer deaths share, applied to ~9.7 million total annual global cancer deaths, gives ~760,000 liver cancer deaths per year — matching the GLOBOCAN 2022 direct estimate of 758,725 to two significant figures. Used to anchor the #3-cancer- killer framing in the body text.
    Independence
    IARC GLOBOCAN is the upstream dataset that WHO and the cancer statistics literature draw from. Treat this source as partially dependent on the Bray 2024 CA paper and the Global Epidemiology PMC paper below — they all point at the same GLOBOCAN compilation.
  2. [2] CA: A Cancer Journal for Clinicians (Bray, Laversanne, Sung, Ferlay, Siegel, Soerjomataram, Jemal) — Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Statistic
    Liver cancer was the third leading cause of cancer death globally in 2022 with 7.8% of all cancer deaths (~760,000 deaths)
    Excerpt
    “"liver (7.8%)" [as the third leading cause of cancer deaths globally, following lung at 18.7% and colorectal at 9.3%] ”
    Source data from
    2024-04-04
    Accessed
    2026-04-11 · archived copy
    Calculation
    The Bray 2024 paper is the canonical peer-reviewed publication behind the GLOBOCAN 2022 release. It is the standard citation for the global-cancer-mortality ranking and is used here to anchor the "#3 cancer killer globally" framing. Liver cancer’s 7.8% share of global cancer deaths places it ahead of female breast (6.9%) and stomach (6.8%), two sites that get far more public attention in high-income countries.
    Independence
    Bray et al. 2024 is the peer-reviewed publication of the GLOBOCAN 2022 compilation summarised in the IARC news item above. Treat as the same line of evidence, presented with different levels of detail.
  3. [3] Journal of the National Cancer Center (via PubMed Central) — Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
    Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
    Statistic
    866,136 new liver cancer cases and 758,725 deaths worldwide in 2022; global mortality-to-incidence ratio 0.86; Eastern Asia concentrates roughly half of global cases; Northern America incidence rate 6.7 per 100,000 vs Eastern Asia 14.7 per 100,000 age-standardised
    Excerpt
    “"In 2022, approximately 866,136 new liver cancer cases and 758,725 related deaths were recorded worldwide, with a global MIR of 0.86. [...] In China and East Asia, chronic hepatitis B virus (HBV) infection and aflatoxin contamination of food are prominent risk factors for liver cancer. [...] In high-HDI regions such as North America and Western Europe, factors such as chronic HCV infection, alcohol overconsumption, excess body fat, and type 2 diabetes may be more prominent contributors to liver cancer." ”
    Source data from
    2024-09-01
    Accessed
    2026-04-11 · archived copy
    Calculation
    This paper is the detailed 2022 liver-cancer-specific breakdown behind the GLOBOCAN headline numbers, and is the source for the regional_breakdown probabilities. The ~0.86 mortality-to-incidence ratio is the key prognosis metric: liver cancer kills ~86% of those diagnosed within a short horizon globally, reflecting late-stage diagnosis and limited curative treatment options in most populations. The Eastern Asia concentration (roughly half of global cases from ~30% of the world’s population) is the single largest regional disparity in the global cancer burden and the basis for the 10x East-Asia-vs-US multiplier in the body text.
    Independence
    Draws on the same GLOBOCAN 2022 compilation as the Bray 2024 paper and the IARC news item; treat as partially dependent with respect to the headline death count. The regional breakdown and risk- factor discussion are the added value beyond the headline figures.
  4. [4] US National Cancer Institute / Surveillance, Epidemiology, and End Results Program (SEER) — Cancer of the Liver and Intrahepatic Bile Duct — Cancer Stat Facts
    Cancer of the Liver and Intrahepatic Bile Duct — Cancer Stat Facts
    Statistic
    US lifetime risk of being diagnosed with liver and intrahepatic bile duct cancer ~1.1%; ~42,240 new cases and ~30,090 deaths estimated for 2025; 5-year relative survival 22.0%; sixth leading cause of cancer death in the US
    Excerpt
    “"Approximately 1.1 percent of men and women will be diagnosed with liver and intrahepatic bile duct cancer at some point during their lifetime, based on 2018-2021 data. [...] The rate of new cases of liver and intrahepatic bile duct cancer was 9.4 per 100,000 men and women per year. [...] The death rate was 6.6 per 100,000 men and women per year. [...] 5-year relative survival: 22.0%." ”
    Source data from
    2025-04-01
    Accessed
    2026-04-11 · archived copy
    Calculation
    SEER is the methodological gold standard for US cancer lifetime risk. The 1.1% lifetime diagnosis figure (≈ 1 in 91) combined with a ~22% five-year survival gives an approximate US lifetime mortality of ~0.85%, which rounds to the ~0.7% figure used as the US lifetime anchor in the regional_breakdown table. The ~9.4 per 100,000 US incidence rate is less than half the global rate in Eastern Asia, which drives the order-of-magnitude regional spread. Used as the direct US anchor and as the prognosis anchor (22% five-year survival is one of the worst among common cancers, behind only pancreatic and oesophageal).
    Independence
    SEER (NCI) is independent of IARC GLOBOCAN — SEER is US-only vital registration and population-based cancer registry data, IARC is a global compilation. Comparing the two anchors the US-vs-global gap.
  5. [5] World Health Organization — Hepatitis B — fact sheet
    Hepatitis B — fact sheet
    Statistic
    254 million people living with chronic hepatitis B infection globally in 2022; ~1.1 million hepatitis B deaths per year mostly from cirrhosis and hepatocellular carcinoma; perinatal HBV infection becomes chronic in ~95% of cases vs <5% in adult-acquired infection
    Excerpt
    “"In 2022, hepatitis B resulted in an estimated 1.1 million deaths, mostly from cirrhosis and hepatocellular carcinoma. [...] WHO estimates that 254 million people were living with chronic hepatitis B infection in 2022, with 1.2 million new infections each year. [...] Hepatitis B infection acquired in adulthood leads to chronic hepatitis in less than 5% of cases, whereas infection in infancy and early childhood leads to chronic hepatitis in about 95% of cases. [...] Some people with chronic hepatitis B will develop progressive liver disease and complications like cirrhosis and hepatocellular carcinoma (liver cancer)." ”
    Source data from
    2024-04-09
    Accessed
    2026-04-11 · archived copy
    Calculation
    WHO’s 1.1 million annual HBV deaths "mostly from cirrhosis and hepatocellular carcinoma" is the primary upstream source for the 25x chronic-HBV personal factor multiplier. Roughly half of global HCC cases are attributable to chronic HBV (the other half split between chronic HCV, alcohol, NAFLD/MASLD, and aflatoxin), and the 254 million chronic HBV carriers worldwide are concentrated in the same East/Southeast Asia and Sub-Saharan Africa regions that account for most global liver cancer mortality. The vaccinated multiplier of ~0.1 reflects the ~95% efficacy of the HBV vaccine in preventing chronic infection when administered in infancy — the intervention that has begun to bend the incidence curve in post-1980s cohorts in Taiwan, China, and elsewhere.
    Independence
    WHO hepatitis B fact sheet draws on separate surveillance pipelines (WHO Global Hepatitis Programme, national seroprevalence surveys) from the IARC GLOBOCAN cancer registry pipeline. Treated as an independent line of evidence on the risk-factor side even though the downstream liver cancer mortality numbers are partially dependent via cause-of-death attribution.
  6. [6] American Cancer Society — Key Statistics About Liver Cancer
    Key Statistics About Liver Cancer
    Statistic
    ~42,340 new US liver cancer cases and ~30,980 deaths projected for 2026 (27,790 new cases in men, 14,550 in women; 19,650 deaths in men, 11,330 in women); US liver cancer incidence has tripled over the past four decades
    Excerpt
    “"About 42,340 new cases (27,790 in men and 14,550 in women) will be diagnosed [...] About 30,980 people (19,650 men and 11,330 women) will die of these cancers [...] Liver cancer incidence rates have tripled in the US over the past 4 decades." ”
    Source data from
    2026-01-13
    Accessed
    2026-04-11 · archived copy
    Calculation
    ACS figures match SEER to within ~2% and are used as the annual US aggregate anchor. The more interesting number here is the three-fold increase in US liver cancer incidence over the past four decades — most of which is attributable to (a) the HCV infection cohort born 1945-1965, (b) rising rates of NAFLD/MASLD driven by obesity and metabolic syndrome, and (c) the ageing of the population. Used as the basis for the third body paragraph on NAFLD/MASLD as an emerging risk factor.
    Independence
    ACS and SEER share the same underlying vital-registration and cancer-registry upstream (NCHS mortality data, NAACCR incidence data). Treat as one combined US line of evidence.

Summarize with AI

Pick an AI below to open with the prompt ready — or copy it and paste anywhere.

1 One click — opens with the prompt ready

Prompt is too long for one-click prefill. Copy it, then open one of the AIs below.

2 Or copy and paste into:
Preview the prompt

Help keep Likelier free

Want more risks covered? Likelier is free and ad-free. Every coffee funds new research, source archiving, and the fact-checking that keep the numbers trustworthy.

Buy me a coffee (opens in new tab)
412 risks with measured probability
1 in 10 1 in 100 1 in 1K 1 in 10K 1 in 100K 1 in 1M 1 in 10M 1 in 100M 1 in 1B certain rarer → Cosmetic surgery abroad risk — 1 in 10 Infant sugar/salt and adult disease — 1 in 10 Endometriosis — 1 in 10 Hair transplant Turkey risk — 1 in 10 Knee replacement — 1 in 10 Chronic painkillers — 1 in 10 Elderly abandonment — 1 in 9.1 Complete tooth loss — 1 in 9.1 Alzheimer's — 1 in 8.3 Sleep deprivation — 1 in 8.3 Smokeless tobacco — 1 in 8.3 Cycling w/o helmet — 1 in 8.0 Bruxism tooth damage — 1 in 7.7 Vision loss — 1 in 6.7 Hernia from lifting — 1 in 6.7 Hip fracture risk — 1 in 6.7 Regular drinking — 1 in 6.7 First heart attack — 1 in 5.9 Infertility — 1 in 5.7 5+ years paid LTC — 1 in 5.6 CTE (football) — 1 in 5.0 Major depression — 1 in 4.9 Hiking injury — 1 in 4.8 Infection from sharing food with child — 1 in 4.2 Lyme disease — 1 in 4.0 Loneliness & health — 1 in 3.8 Job loss & depression — 1 in 3.7 Inheriting AUD risk — 1 in 3.5 Alcohol use disorder — 1 in 3.4 Menopause CV risk acceleration — 1 in 3.0 Silent diabetes — 1 in 3.0 Flying with cold — 1 in 2.9 Tick illness (forest) — 1 in 2.9 Silent high cholesterol — 1 in 2.9 Grandparent loss in childhood — 1 in 2.8 Pacifier floor drop — 1 in 2.8 Drug-resistant infection — 1 in 2.6 No marrow match — 1 in 2.4 Nursing home admission — 1 in 2.2 Skipping dental checkups — 1 in 2.1 False-positive mammogram — 1 in 2.0 Regular smoking — 1 in 2.0 Travelers' diarrhea — 1 in 2.0 Adventure sports — 1 in 1.8 Family caregiver probability — 1 in 1.8 LTC need after 65 — 1 in 1.8 Widowhood probability — 1 in 1.7 Unprotected sex — 1 in 1.5 Silent hypertension — 1 in 1.3 Chronic back pain — 1 in 1.3 Hand hygiene — 1 in 1.0 Cancer (any) — 1 in 7.1 E-scooter no helmet — 1 in 4.5 E-bike no helmet — 1 in 4.0 Mishandled luggage — 1 in 3.7 Deer collision — 1 in 2.7 At-fault injury crash — 1 in 2.5 Flight cancellation — 1 in 1.8 Trip disruption: war or disaster — 1 in 1.7 Home burglary (global) — 1 in 9.1 Hitchhiking assault — 1 in 8.8 Mail check fraud — 1 in 7.7 Child sexual abuse — 1 in 6.8 Stalking — 1 in 6.2 Student sexual assault — 1 in 5.7 Domestic violence — 1 in 3.7 Night walk assault — 1 in 3.6 Bicycle theft — 1 in 2.9 Sexual assault — 1 in 2.9 Home burglary — 1 in 2.6 Sexual harassment (lifetime) — 1 in 1.6 Water scarcity — 1 in 2.5 Carrington-class solar storm — 1 in 1.9 WAIS tipping point — 1 in 1.1 Indoor cat escape harm — 1 in 10 Off-leash dog bite — 1 in 8.9 Rabbit dies in 4 years — 1 in 3.3 Dog bite (non-fatal) — 1 in 1.8 Hamster dies before teenager — 1 in 1.0 Vitamin D gap — 1 in 2.9 Undercooked food — 1 in 1.6 Raw meat cross-contamination — 1 in 1.4 Food left out — 1 in 1.2 AI voice scam — 1 in 2.9 Online scam loss — 1 in 2.5 Teen cyberbullying — 1 in 2.0 Kids & explicit content — 1 in 1.9 Data breach — 1 in 1.1 Miscarriage — 1 in 6.7 Teen suicide attempt — 1 in 5.6 Postpartum depression — 1 in 4.8 Painkiller before infant vaccination — 1 in 3.8 Excessive pregnancy weight — 1 in 2.6 Unvaxxed child & measles — 1 in 2.0 Elder fraud loss — 1 in 10 Pension fund collapse — 1 in 10 Personal bankruptcy — 1 in 10 Housing crash — 1 in 8.3 Crypto total loss — 1 in 6.7 IRS audit — 1 in 6.7 Visa overstay deportation — 1 in 5.6 Long term disability working age — 1 in 4.0 Student loan default — 1 in 3.8 Whistleblower retaliation — 1 in 3.2 Career obsolescence — 1 in 2.9 Forced job exit before retirement — 1 in 2.9 Retirement shortfall — 1 in 2.6 Divorce — 1 in 2.4 Burst pipe damage — 1 in 2.2 Workplace bullying — 1 in 2.1 Deportation (undocumented) — 1 in 1.8 Funeral cost shock — 1 in 1.8 Identity theft — 1 in 1.7 Credit card fraud — 1 in 1.5 School bullying — 1 in 1.5 Insurance claim denial — 1 in 1.4 Frontline soldier casualty — 1 in 1.3 Economic recession — 1 in 1.0 Stock market crash — 1 in 1.0 Hail roof damage — 1 in 3.0 Dry toilet paper harm — 1 in 100 Secondhand smoke — 1 in 91 Gaming disorder (adults) — 1 in 83 High-heel ER visit — 1 in 79 Child throwing object — 1 in 67 Medication reaction — 1 in 58 Cat litter toxoplasmosis — 1 in 48 Mental health LTD claim — 1 in 45 Drug overdose — 1 in 42 Benzo dependence — 1 in 40 Tap water lead — 1 in 40 Medication misuse — 1 in 35 Traumatic brain injury — 1 in 33 Hospital infection — 1 in 31 Air pollution — 1 in 29 End-stage kidney disease — 1 in 29 Traveler's diarrhea (water) — 1 in 26 Skiing injury — 1 in 26 Bipolar disorder — 1 in 23 Dental tourism complication — 1 in 20 Pet parasites — 1 in 20 Undiagnosed ADHD — 1 in 20 Adult-onset food allergy — 1 in 19 Indoor cooking smoke — 1 in 18 Non-Alzheimer's dementia — 1 in 17 Working-age disabling stroke — 1 in 17 Cannabis use disorder — 1 in 16 Stroke — 1 in 15 Parent death/disability — 1 in 14 Severe hearing loss — 1 in 14 Type 2 diabetes — 1 in 13 Appendicitis — 1 in 13 Untreated depression — 1 in 13 Untreated back pain disability — 1 in 13 Heart disease — 1 in 12 Medical error death — 1 in 12 Compulsive sexual behavior — 1 in 12 Eating disorder — 1 in 11 Hip replacement — 1 in 11 Kidney stones — 1 in 11 Sedentary lifestyle — 1 in 11 Salon infection — 1 in 11 Ovarian cancer — 1 in 91 Colorectal cancer — 1 in 77 Breast cancer — 1 in 59 Liver cancer — 1 in 59 Lung cancer — 1 in 56 Prostate cancer — 1 in 50 Melanoma (UV) — 1 in 29 Low-fiber CRC risk — 1 in 23 Red meat & CRC — 1 in 21 Charred meat & cancer — 1 in 20 Maintenance crash — 1 in 83 Driving on sedating meds — 1 in 77 Texting + driving — 1 in 56 Driving after cannabis — 1 in 53 Eating while driving — 1 in 53 Unbelted crash death — 1 in 53 Speeding 20% over limit — 1 in 48 Motorcycle no helmet — 1 in 45 Spaceflight (astronaut) — 1 in 42 Video watching + driving — 1 in 32 Drowsy driving — 1 in 26 E-scooter injury — 1 in 26 Cruise ship norovirus — 1 in 24 Driving at 0.10% BAC — 1 in 16 Catalytic converter theft — 1 in 83 Pickpocketed while traveling — 1 in 38 Stabbed in an assault — 1 in 37 Vehicle theft — 1 in 34 Street robbery / mugging — 1 in 26 Wrongful conviction — 1 in 24 Drink spiking — 1 in 17 Protest under autocracy — 1 in 12 AMOC collapse — 1 in 20 Sting anaphylaxis — 1 in 50 Cat collar injury — 1 in 25 Fish bone injury — 1 in 68 Restaurant food poisoning — 1 in 58 Vegetarian deficiency — 1 in 25 Intimate deepfake — 1 in 25 Social media problematic use — 1 in 13 Infant fall — 1 in 100 Childbirth death (SSA) — 1 in 55 Co-sleeping death — 1 in 43 Toddler stair fall — 1 in 37 Play swing & slide injury — 1 in 33 Autism diagnosis — 1 in 31 C-section complications — 1 in 29 Toy injury requiring ER (child) — 1 in 21 Preeclampsia — 1 in 20 Severe birth tearing — 1 in 17 Gestational diabetes — 1 in 13 Child fall head injury — 1 in 12 Sports betting financial ruin — 1 in 100 Fighter pilot death — 1 in 48 Commercial fishing career death — 1 in 45 Logging career death — 1 in 34 Dying without heir — 1 in 33 Medical bankruptcy — 1 in 25 Compulsive buying disorder — 1 in 20 Rental listing scam loss — 1 in 20 Mortgage foreclosure — 1 in 14 Musculoskeletal LTD claim — 1 in 14 Day-trading losses — 1 in 13 Extremist govt catastrophe — 1 in 13 Hurricane home destruction — 1 in 17 LASIK complications — 1 in 1,000 Infant pool submersion — 1 in 800 MS — 1 in 769 Workplace fatality — 1 in 690 Typhoid fever — 1 in 654 Unsafe imported products — 1 in 565 Brain aneurysm — 1 in 400 COVID-19 — 1 in 400 Fireworks injury — 1 in 385 Sickle cell disease — 1 in 365 Counterfeit medicine — 1 in 361 Spinal cord injury — 1 in 313 Childhood cancer diagnosis — 1 in 285 Next pandemic death — 1 in 208 Dengue (travel) — 1 in 200 Skipping daily showers — 1 in 200 Not scrubbing feet — 1 in 200 Marrow donation risk — 1 in 167 Schizophrenia — 1 in 143 Accidental fall — 1 in 135 Parkinson's — 1 in 125 Sudden death during exercise — 1 in 123 Suicide (US) — 1 in 121 Opioid addiction — 1 in 114 Tuberculosis (global) — 1 in 108 Radon cancer — 1 in 435 Testicular cancer — 1 in 250 Cervical cancer — 1 in 167 Pancreatic cancer — 1 in 125 Pedestrian death — 1 in 806 Motorcycle crash — 1 in 694 Boating drowning — 1 in 685 Driver kills pedestrian — 1 in 552 Phone-distracted walking injury — 1 in 400 EV battery fire — 1 in 333 Cyclist killed by car — 1 in 196 Hand-held phone call + driving — 1 in 143 Petrol car fire — 1 in 125 Self-driving car fatality — 1 in 115 Car crash — 1 in 105 Firefighter duty death — 1 in 455 Police duty death — 1 in 313 Homicide — 1 in 287 Pig-butchering scam — 1 in 106 Extreme heat — 1 in 333 Climate change death — 1 in 204 Swallowed bee/wasp — 1 in 500 Bat bite & rabies — 1 in 238 Mosquito-borne disease — 1 in 190 Food poisoning (global) — 1 in 317 Solar panel fire — 1 in 667 Untreated childhood scoliosis — 1 in 1,000 Child window fall — 1 in 855 Walker stair fall — 1 in 625 Baby walker injury — 1 in 455 Maternal mortality — 1 in 272 Untreated childhood flat feet — 1 in 250 Maternal age & birth defects — 1 in 200 Child death (<18) — 1 in 143 Caving career death — 1 in 167 EMS duty death — 1 in 794 Civilian war casualty — 1 in 499 Soldier in combat — 1 in 270 Mining career death — 1 in 214 Gambling financial ruin — 1 in 159 Wildfire home destruction — 1 in 120 Lightning home fire — 1 in 105 Malaria (travel) — 1 in 10,000 Infection from shared drink — 1 in 10,000 Chagas disease — 1 in 8,475 Wild berry fox tapeworm — 1 in 8,475 Schistosomiasis death — 1 in 6,667 Sudden death (young adult) — 1 in 3,922 Unsafe wiring — 1 in 3,390 Sepsis from wound — 1 in 2,857 Anesthesia awareness — 1 in 2,500 Heat stroke (outdoor) — 1 in 1,905 House fire — 1 in 1,818 Rabies from dogs — 1 in 1,449 Drowning — 1 in 1,379 Shallow-water diving SCI — 1 in 1,111 Choking — 1 in 1,099 EVALI vaping hospitalization — 1 in 1,064 Betel nut cancer — 1 in 1,290 Blood clot (flight) — 1 in 4,651 Killing a cyclist — 1 in 3,937 Teen road-crash death — 1 in 3,030 Child rear bike seat — 1 in 2,500 Child without restraint — 1 in 2,000 Fatal police encounter — 1 in 4,739 Honor killing — 1 in 2,381 Intimate-partner homicide — 1 in 1,767 Hurricane — 1 in 8,929 Drought famine death — 1 in 6,536 Blizzard death — 1 in 4,367 Earthquake — 1 in 3,802 Dog chocolate death — 1 in 2,000 Food poisoning (US) — 1 in 1,862 Fish mercury — 1 in 1,695 Phone/laptop battery fire — 1 in 1,136 SIDS — 1 in 7,143 Laundry pod ingestion — 1 in 6,494 Untreated infant hip dysplasia — 1 in 5,000 Pool drowning — 1 in 2,299 War (civilian) — 1 in 2,000 Fatal bee/wasp sting — 1 in 76,923 Anesthesia death — 1 in 50,000 Dog hot car death — 1 in 41,667 Anaphylaxis — 1 in 27,548 Chiropractic neck manipulation — 1 in 16,667 CO poisoning — 1 in 14,006 Hepatitis A (travel) — 1 in 12,500 Skipping allergy immunotherapy — 1 in 11,111 Acrylamide & cancer — 1 in 16,667 Bus crash — 1 in 100,000 Plane crash — 1 in 58,824 Child pedestrian (residential) — 1 in 45,455 Railroad crossing death — 1 in 20,704 Child bike trailer — 1 in 14,286 Acid attack — 1 in 89,286 Terrorism — 1 in 77,519 Child stranger abduction — 1 in 38,760 Stranger kidnapping — 1 in 35,211 Dowry death — 1 in 13,158 Accidental gun death — 1 in 11,299 Wildfire — 1 in 100,000 Tornado — 1 in 80,645 Tsunami — 1 in 52,632 Ocean drowning — 1 in 29,155 Flood — 1 in 20,202 Landslide death — 1 in 18,416 Supervolcano eruption — 1 in 12,376 Crocodile attack — 1 in 84,746 Bee sting — 1 in 78,927 Fatal scorpion sting — 1 in 26,110 Plastic container leaching — 1 in 16,949 Infant in car seat — 1 in 64,935 Bouncer chair fall — 1 in 60,606 Toddler choking — 1 in 50,000 Unsupervised infant choking — 1 in 50,000 Magnet ingestion — 1 in 12,048 Snorkeling death — 1 in 21,739 Pet in transport — 1 in 20,000 Landmine or UXO injury — 1 in 14,728 Vaccine reaction — 1 in 763,359 Aluminum & Alzheimer's — 1 in 169,492 Residential gas leak — 1 in 140,845 Child hot car death — 1 in 102,041 Glyphosate & cancer — 1 in 1,000,000 Teflon cookware cancer — 1 in 169,492 Roller coaster injury — 1 in 312,500 Cruise ship accident — 1 in 188,679 Ferry sinking — 1 in 133,333 Turbulence injury — 1 in 114,943 School shooting — 1 in 192,308 Mass shooting — 1 in 113,636 Nuclear accident — 1 in 833,333 Avalanche — 1 in 210,526 Lightning — 1 in 209,205 Snake bite — 1 in 884,956 Spider bite — 1 in 833,333 Hippo attack — 1 in 564,972 Dog bite — 1 in 142,045 Pesticide residue — 1 in 1,000,000 Dirty can illness — 1 in 200,000 PLA bioplastic harm — 1 in 169,492 Charger left plugged in — 1 in 200,000 Infant swing death — 1 in 714,286 Child blind cord strangulation — 1 in 416,667 Child plastic bag suffocation — 1 in 263,158 Button battery — 1 in 250,000 Inclined sleeper death — 1 in 238,095 Elevator/escalator death — 1 in 188,324 Japanese encephalitis (travel) — 1 in 2,000,000 Kid + front airbag — 1 in 10,000,000 Asteroid impact — 1 in 1,351,351 Banana spider eggs — 1 in 10,000,000 Shark attack — 1 in 5,681,818 Bear attack — 1 in 3,787,879 Wild berry poisoning — 1 in 2,222,222 Space debris hits property — 1 in 10,000,000 Piranha attack — 1 in 135,135,135 Phone at gas pump — 1 in 1,000,000,000 Phone on plane — 1 in 1,000,000,000 Alien contact — 1 in 169,491,525
Lottery jackpot 1 in 95,238